Title

Update on Diabetic Nephropathy: Core Curriculum 2018.

Document Type

Article

Publication Date

6-1-2018

Publication Title

American journal of kidney diseases : the official journal of the National Kidney Foundation

Abstract

Diabetic kidney disease and diabetic nephropathy are the leading cause of end-stage kidney disease in the United States and most developed countries. Diabetes accounts for 30% to 50% of the incident cases of end-stage kidney disease in the United States. Although this represents a significant public health concern, it is important to note that only 30% to 40% of patients with diabetes develop diabetic nephropathy. Specific treatment of patients with diabetic nephropathy can be divided into 4 major arenas: cardiovascular risk reduction, glycemic control, blood pressure control, and inhibition of the renin-angiotensin system (RAS). Recommendations for therapy include targeting a hemoglobin A

PubMed ID

29398179

Volume

71

Issue

6

First Page

884

Last Page

895

Share

COinS